Home » Topics » BioWorld Science, Nephrology

BioWorld Science, Nephrology
RSS

Recent Biogen Idec patents report novel antifibrotic agents

Sep. 19, 2008

New treatment options for urinary incontinence described in recent Toray patent

Sep. 9, 2008

Protox completes enrollment in phase II trial of PRX-302 in BPH

Sep. 9, 2008

Ikaria acquires North American rights to Lucassin for HRS from Orphan Therapeutics

Sep. 4, 2008

Novel spirofuran potassium channel openers designed for urinary incontinence

Sep. 3, 2008

Terlipressin benefits patients awaiting liver transplant with renal failure, hyponatremia

Aug. 22, 2008

4SC describes new compounds for urinary incontinence in recent patent

Aug. 21, 2008

Watson successfully completes pilot clinical study of Stellar's Uracyst in interstitial cystitis

Aug. 20, 2008

CPEX and Serenity collaborate on drug candidate for urology indication

Aug. 5, 2008

Study investigates cardiac safety profile of antimuscarinic drugs for overactive bladder

July 21, 2008

Popular Stories

Today's news in brief
BioWorld
BioWorld briefs for May 15, 2026.
ASGCT 2026: Circular RNA, the new beast in gene and cell therapy
BioWorld
Circular RNA (circRNA) is not a new concept, but it is a novel strategy in the field of gene and cell therapy. While mRNA vaccines have revolutionized medicine,...
Advancing the 'best of both' – BMS, Hengrui enter $15.2B deal
BioWorld
In a deal potentially worth up to $15.2 billion, Jiangsu Hengrui Pharmaceuticals Co. Ltd. is joining efforts with Bristol Myers Squibb Co. to advance 13 early...
News in brief
BioWorld Asia
BioWorld Asia briefs for May 12, 2026
ASGCT 2026: Uncovering the mechanisms of AAV toxicity
BioWorld
Gene therapies rely on vectors to reach the target tissue where they act, such as adeno-associated viruses (AAVs) or lipid nanoparticles (LNPs), among other...